{"id":379568,"date":"2020-11-12T08:03:41","date_gmt":"2020-11-12T13:03:41","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379568"},"modified":"2020-11-12T08:03:41","modified_gmt":"2020-11-12T13:03:41","slug":"mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/","title":{"rendered":"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MARIETTA, Ga., Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMiMedx\u201d or the \u201cCompany\u201d), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, MiMedx Chief Executive Officer, and Peter M. Carlson, MiMedx Chief Financial Officer, will present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020, beginning at 9:30 am, Eastern Time.<\/p>\n<p align=\"justify\">A live webcast of the presentation will be available on the Events page of the Investors section of the Company\u2019s website or through the conference site by using the link below.<\/p>\n<p>\n        <strong>Date<\/strong>: Thursday, November 19, 2020<br \/><strong>Time<\/strong>: 9:30 AM ET<br \/><strong>Webcast<\/strong>: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eecWrXWlhWIIl9W_TeadN9Bu5Dcs4_ynYQUtn75i3-IXDWTpTPzTENUcvLYoPBBfhJAsaEFMtEZO5LZ15Kce8Wl5l4Eoqseb6DCV8PqomlYRQx5-HxHrLLIZmpdiHFV-K-qg2sZgjd8L-Rq-f5sJAulZRngGbcP21tRP7G36XeM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/wsw.com\/webcast\/canaccord44\/mdxg\/2454624<\/a>\u00a0<\/p>\n<p align=\"justify\">A replay of the webcast will be available for approximately 45 days on the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gaklBf4ViFd5GPAsoE-v3kA0Yq4vP3mztsG3NgExHU85SpONUZ0Ian5U_iXQhboA2UUJFC6aSjUwOn3UATxMww==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.mimedx.com<\/a> following the conclusion of the presentation.<\/p>\n<p align=\"justify\">\n        <strong>About MiMedx<\/strong><br \/>\n        <br \/>MiMedx<sup>\u00ae<\/sup>\u00a0is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION<sup>\u00ae<\/sup>\u00a0process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied more than two million allografts, through both direct and consignment shipments. For additional information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gaklBf4ViFd5GPAsoE-v3tQEBOP2uB7_01HH8kWEwWa6GDOrExHjFcteigu2wj2LJ8D4ZlhSaTIvlBFRgzecww==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.mimedx.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contact<\/strong><br \/>\n        <br \/>Hilary Dixon<br \/>Investor Relations &amp; Corporate Communications<br \/>770.651.9066<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h7AcMPMkah9adAh8j1uvs6LG0FS2WuUPI_Kd0wiiplyV5ef6gwUh7C0apFJH8jRW30KOWtJsktBWWA2uFIy1d13QVe-th_v3R3ZYp9HXDNDx555wytVV6E9pOIDdjpiF\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investorrelations@mimedx.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MARIETTA, Ga., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMiMedx\u201d or the \u201cCompany\u201d), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, MiMedx Chief Executive Officer, and Peter M. Carlson, MiMedx Chief Financial Officer, will present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020, beginning at 9:30 am, Eastern Time. A live webcast of the presentation will be available on the Events page of the Investors section of the Company\u2019s website or through the conference site by using the link below. Date: Thursday, November 19, 2020Time: 9:30 AM ETWebcast: https:\/\/wsw.com\/webcast\/canaccord44\/mdxg\/2454624\u00a0 A replay of the webcast will be available for approximately 45 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379568","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MARIETTA, Ga., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMiMedx\u201d or the \u201cCompany\u201d), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, MiMedx Chief Executive Officer, and Peter M. Carlson, MiMedx Chief Financial Officer, will present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020, beginning at 9:30 am, Eastern Time. A live webcast of the presentation will be available on the Events page of the Investors section of the Company\u2019s website or through the conference site by using the link below. Date: Thursday, November 19, 2020Time: 9:30 AM ETWebcast: https:\/\/wsw.com\/webcast\/canaccord44\/mdxg\/2454624\u00a0 A replay of the webcast will be available for approximately 45 &hellip; Continue reading &quot;MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T13:03:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\",\"datePublished\":\"2020-11-12T13:03:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"},\"wordCount\":238,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\",\"name\":\"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=\",\"datePublished\":\"2020-11-12T13:03:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/","og_locale":"en_US","og_type":"article","og_title":"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","og_description":"MARIETTA, Ga., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMiMedx\u201d or the \u201cCompany\u201d), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, MiMedx Chief Executive Officer, and Peter M. Carlson, MiMedx Chief Financial Officer, will present at the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum on Thursday, November 19, 2020, beginning at 9:30 am, Eastern Time. A live webcast of the presentation will be available on the Events page of the Investors section of the Company\u2019s website or through the conference site by using the link below. Date: Thursday, November 19, 2020Time: 9:30 AM ETWebcast: https:\/\/wsw.com\/webcast\/canaccord44\/mdxg\/2454624\u00a0 A replay of the webcast will be available for approximately 45 &hellip; Continue reading \"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T13:03:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum","datePublished":"2020-11-12T13:03:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/"},"wordCount":238,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/","name":"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=","datePublished":"2020-11-12T13:03:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDYzOSMzODIzMzgwIzIwMTA1Nzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-to-present-at-canaccord-genuity-virtual-medtech-diagnostics-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MiMedx To Present At Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379568"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379568\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}